Clinical Trial

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

Name: 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC — clinical trial record (NCT07043270)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this research is to study the effects and safety of alternating neoadjuvant chemotherapy on borderline resectable pancreatic cancer.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-06-20; most recent amendment 2025-10-16.

Status change: Not Yet Recruiting → Recruiting 2025-10-16

Trial Details

NCT Number	NCT07043270
Lead Sponsor	Dartmouth-Hitchcock Medical Center
Conditions	Pancreas Adenocarcinoma
Enrollment	35 participants
Start Date	2025-09-29
Primary Completion	2028-07-01 (estimated)
Study Completion	2029-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-06